4.7 Review

Injectable matrices and scaffolds for drug delivery in tissue engineering

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 59, Issue 4-5, Pages 263-273

Publisher

ELSEVIER
DOI: 10.1016/j.addr.2007.03.013

Keywords

injectable; biomaterials; tissue engineering; drug delivery; scaffolds

Funding

  1. NIAMS NIH HHS [R01 AR48756] Funding Source: Medline
  2. NIDCR NIH HHS [R01 DE15164] Funding Source: Medline
  3. NIGMS NIH HHS [T32 GM07330, 2 T32 GM008362] Funding Source: Medline

Ask authors/readers for more resources

Injectable matrices and depots have been the subject of much research in the field of drug delivery. The classical tissue engineering paradigm includes a matrix or scaffold to facilitate tissue growth and provide structural support, cells, and the delivery of bioactive molecules. As both tissue engineering and drug delivery techniques benefit from the use of injectable materials due to the minimal invasiveness of an injection, significant crossover should be observed between injectable materials in both fields. This review aims to outline injectable materials and processing techniques used in both tissue engineering and drug delivery and to describe methods by which current injectable materials in the field of drug delivery can be adapted for use as injectable scaffolds for tissue engineering. (c) 2007 Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available